Oxygen therapies or haemoglobin-based oxygen carriers are other names for artificial blood substitutes. It's utilised to replace blood transfusions by simulating the function of biological blood. Artificial blood is used to replace banked red blood cell transfusions and is designed to solve restrictions such as a lack of blood, high risk of contamination, and the need for cross matching. Artificial blood Market transfusions have a number of dangers, including the transmission of infectious diseases, transfusion responses, transfusion-related acute lung injury, delayed postoperative wound healing, immunomodulation, and the chance of cancer recurrence. It holds out the prospect of novel and life-saving medicinal treatments.
Click here for Artificial Blood Market Report: https://www.coherentmarketinsights.com/market-insight/artificial-bloodmarket-11